5 Biotechs Drawing Buyout Buzz in 2018
Here are five possible acquisition targets to keep an eye on. Source: BioSpace
Here are five possible acquisition targets to keep an eye on. Source: BioSpace
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace
Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year. Source: BioSpace
The latest funding round gives XtalPi $20M in the bank, which the company said makes it "one of the top-funded AI-powered biotechs." Source: BioSpace
Wong Lap Kwong Medicine Company drew a warning from the FDA for failing to identify active pharmaceutical ingredients and to establish procedures for numerous basic functions in its Hong Kong…
A drug research firm is suing the FDA for $50 million, arguing the agency issued a disciplinary letter that “annihilated” the company based on evidence fabricated by a rogue employee.…
The Drug Enforcement Administration issued a final rule expanding the types of practitioners who may temporarily prescribe narcotic drugs for opioid addiction treatment and improving treatment availability in underserved areas.…
CBER’s agenda for 2018 states that it is considering the release of more than a dozen guidance documents, including new draft guidance on testing retroviral gene therapy products and on…
GigaGen completed relocation to One Tower Place in late December 2017. Source: BioSpace
Having a stock double in value is a good thing. Source: BioSpace